Literature DB >> 11911333

The glucose breath test: a diagnostic test for small bowel stricture(s) in Crohn's disease.

Daniel Mishkin1, Francis M Boston, David Blank, Morty Yalovsky, Seymour Mishkin.   

Abstract

The aim of this study was to determine whether an indirect noninvasive indicator of proximal bacterial overgrowth, the glucose breath test, was of diagnostic value in inflammatory bowel disease. Twenty four of 71 Crohn's disease patients tested had a positive glucose breath test. No statistical conclusions could be drawn between the Crohn's disease activity index and glucose breath test status. Of patients with radiologic evidence of small bowel stricture(s), 96.0% had a positive glucose breath test, while only one of 46 negative glucose breath test patients had a stricture. The positive and negative predictive values for a positive glucose breath test as an indicator of stricture formation were 96.0% and 97.8%, respectively. This correlation was not altered in Crohn's disease patients with fistulae or status postresection of the terminal ileum. The data in ulcerative colitis were nondiagnostic. In conclusion, the glucose breath test appears to be an accurate noninvasive inexpensive diagnostic test for small bowel stricture(s) and secondary bacterial overgrowth in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911333     DOI: 10.1023/a:1017991313789

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Cortisone in ulcerative colitis; final report on a therapeutic trial.

Authors:  S C TRUELOVE; L J WITTS
Journal:  Br Med J       Date:  1955-10-29

2.  Glucose malabsorption associated with rapid intestinal transit.

Authors:  J H Sellin; R Hart
Journal:  Am J Gastroenterol       Date:  1992-05       Impact factor: 10.864

3.  The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth.

Authors:  J M Rhodes; P Middleton; D P Jewell
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

4.  Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome.

Authors:  R A Giannella; W R Rout; P P Toskes
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

5.  Medical therapy for Crohn's disease.

Authors:  S B Hanauer
Journal:  Curr Opin Gastroenterol       Date:  1999-07       Impact factor: 3.287

6.  Increased prevalence of lactose malabsorption in Crohn's disease patients at low risk for lactose malabsorption based on ethnic origin.

Authors:  B Mishkin; M Yalovsky; S Mishkin
Journal:  Am J Gastroenterol       Date:  1997-07       Impact factor: 10.864

7.  Ileoanal anastomosis with reservoirs: complications and long-term results.

Authors:  P Belliveau; J Trudel; C A Vasilevsky; B Stein; P H Gordon
Journal:  Can J Surg       Date:  1999-10       Impact factor: 2.089

8.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

9.  The human intestinal microflora.

Authors:  G L Simon; S L Gorbach
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

10.  Altered myoelectric activity in the experimental blind loop syndrome.

Authors:  P G Justus; A Fernandez; J L Martin; C E King; P P Toskes; J R Mathias
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

View more
  8 in total

Review 1.  Gastroduodenal "Dysbiosis": a New Clinical Entity.

Authors:  Ayesha Shah; Mark Morrison; Gerald J Holtmann
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 2.  Small intestinal bacterial overgrowth syndrome.

Authors:  Jan Bures; Jiri Cyrany; Darina Kohoutova; Miroslav Förstl; Stanislav Rejchrt; Jaroslav Kvetina; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

3.  Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy.

Authors:  Massimiliano Filosto; Mauro Scarpelli; Paola Tonin; Silvia Testi; Maria Sofia Cotelli; Mara Rossi; Andrea Salvi; Alberto Grottolo; Valentina Vielmi; Alice Todeschini; Gian Maria Fabrizi; Alessandro Padovani; Giuliano Tomelleri
Journal:  J Inherit Metab Dis       Date:  2011-04-19       Impact factor: 4.982

4.  Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatment.

Authors:  Cristina Sánchez-Montes; Vicente Ortiz; Guillermo Bastida; Ester Rodríguez; María Yago; Belén Beltrán; Mariam Aguas; Marisa Iborra; Vicente Garrigues; Julio Ponce; Pilar Nos
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

5.  Small intestinal bacterial overgrowth in patients with inflammatory bowel disease: A case-control study.

Authors:  Uday C Ghoshal; Ankur Yadav; Bushra Fatima; Anand Prakash Agrahari; Asha Misra
Journal:  Indian J Gastroenterol       Date:  2021-08-14

6.  Small intestinal bacterial overgrowth in inflammatory bowel disease.

Authors:  Ayesha Shah; Gerald Holtmann
Journal:  Indian J Gastroenterol       Date:  2022-01-15

7.  Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.

Authors:  Shirley Cohen-Mekelburg; Zaid Tafesh; Elliot Coburn; Russell Weg; Neena Malik; Colleen Webb; Hoda Hammad; Ellen Scherl; Brian P Bosworth
Journal:  Dig Dis Sci       Date:  2018-05-14       Impact factor: 3.199

8.  Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.

Authors:  Jochen Klaus; Ulrike Spaniol; Guido Adler; Richard A Mason; Max Reinshagen; Christian von Tirpitz C
Journal:  BMC Gastroenterol       Date:  2009-07-30       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.